Moreover, the effects of eFT508 could be reversed by TrkB/BDNF antagonism, suggesting the critical role of eIF4E in the etiology of neuroinflammation-associated depression via TrkB/BDNF signaling. Here, EIF4E is linked to major depressive disorder.